PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Burgos University Hospital, Spain. Electronic address: eiglesiasjulian@gmail.com.\', \'Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Burgos University Hospital, Spain.\', \'Department of Neurosurgery, Burgos University Hospital, Spain.\', \'Department of Rheumatology, Burgos University Hospital, Spain.\', \'Department of Pharmacy, Burgos University Hospital, Spain.\', \'Department of Intensive Care Medicine, Burgos University Hospital, Spain.\', \'Department of Pneumology, Burgos University Hospital, Spain.\', \'Department of Anesthesiology, Burgos University Hospital, Spain.\', \'Department of Internal Medicine, Burgos University Hospital, Spain.\', \'Infectious Diseases Unit, Department of Internal Medicine, Burgos University Hospital, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0896-8411(20)30163-310.1016/j.jaut.2020.102537
?:hasPublicationType
?:journal
  • Journal of autoimmunity
is ?:pmid of
?:pmid
?:pmid
  • 32843231
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.046
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all